Gilead Sciences, Inc.

NASDAQ:GILD   3:35:53 PM EDT
66.28
-0.23 (-0.35%)
Products

Gilead Sciences Announces Steps To Expand Availability Of Remdesivir In India

Published: 04/27/2021 01:15 GMT
Gilead Sciences, Inc. (GILD) - Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India.
Gilead Sciences Inc - Will Donate a Minimum of 450,000 Vials of Veklury(®) to Government of India.
Gilead Sciences Inc - Committed to Providing Support to Voluntary Licensees Based Outside of India to Increase Their Production Capacity.
Gilead - Planned Support to Voluntary Licensees Based Outside of India Will Include Donation of Api to Licensees With a View to Accelerate Production.
Gilead - Co's Licensees Based in India Significantly Accelerated Production of Remdesivir, Which is Expected to Increase Its Availability in Coming Weeks.